interferon release assay for coxiella burnetii q fever
play

Interferon- release assay for Coxiella burnetii Q fever Caused by - PowerPoint PPT Presentation

Interferon- release assay for Coxiella burnetii Q fever Caused by bacteria Coxiella burnetii Human infections after shedding by animals (goats, sheep, cattle, etc.) Found worldwide except New Zealand Main type of diagnostics: serology Main


  1. Interferon- ɣ release assay for Coxiella burnetii

  2. Q fever Caused by bacteria Coxiella burnetii Human infections after shedding by animals (goats, sheep, cattle, etc.) Found worldwide except New Zealand Main type of diagnostics: serology Main treatment: antibiotics (doxycycline) Largest outbreak : The Netherlands in 2007-2010: 100,000 infections by goats Vaccination programs: in Australia 2

  3. What ’ s new? First diagnostic test based on cellular immune response In vitro blood stimulation with killed off Coxiella bacteria* Interferon- ɣ production used as response measure * Schoffelen et al., 2013 3

  4. Q-detect looks at T-cell response Humoral immunity B-cells Serology IgG - IgM 4

  5. Q-detect looks at T-cell response Humoral immunity Cellular immunity + B-cells T-cells Q-detect Serology Interferon ɣ IgG - IgM 5

  6. Q-detect way of working Blood withdrawal (8 ml) Stimulation with killed bacteria in biosafety level 2 laboratory 6

  7. Q-detect way of working 24 h incubation @37 ⁰ C Washing and colouring (ELISA) Interferon- ɣ measurement 7

  8. Q-detect results Results based on individual: • Coxiella induced IFN- γ production (cox - neg) • Relative Coxiella Response vs. PHA Large study* in high prevalence community compares IFA** to Q-detect ( > 5 years after infection ) 1000 Q-detect finds 80% more Q fever infected people 900 800 700 +68% 600 500 400 300 IFA 200 100 Q-detect 0 Q fever positive * Q-Herpen II Study, 2014, >1,500 people included, financed by the Dutch Ministery of Health, Welfare and Sports 8 ** Focus Diagnostics

  9. Product information Validated on > 1,600 volunteers Sensitivity: 94% (at prevalence of 10%) Specificity: > 92% CE marked (Dec 2014) Can be adapted for veterinary use Q-detect in combination with IL-2 investigated for QFS 9

  10. Innatoss Laboratories Molenstraat 110, 5342 CC Oss, the Netherlands (Pivot Park, Room RE 2428) Contact: Maarten van der Zanden E: maarten.vanderzanden@innatoss.com T: +31 637353787 10

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend